Pfizer Limited

Symbol: PFIZER.BO

BSE

4108.65

INR

Market price today

  • 39.1665

    P/E Ratio

  • 21.0602

    PEG Ratio

  • 187.96B

    MRK Cap

  • 0.01%

    DIV Yield

Pfizer Limited (PFIZER-BO) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

0.63%

Operating Profit Margin

0.25%

Net Profit Margin

0.23%

Return on Assets

0.00%

Return on Equity

0.15%

Return on Capital Employed

0.00%

Company general description and statistics

Sector: Healthcare
Industry: Drug Manufacturers - General
CEO:Ms. Meenakshi Nevatia
Full-time employees:1702
City:Mumbai
Address:The Capital
IPO:2000-01-17
CIK:

Pfizer Limited engages in manufacturing, marketing, trading, and export of pharmaceutical products in India and internationally. The company offers its products in various therapeutic areas, including neuro/central nervous system, hormones, cardiovascular, hemophilia, anti-infectives, gynecology, pain/analgesics, orthopedic, oncology, urology, anti-parasitic, gastro intestinal, vaccines, respiratory, and vitamins/minerals/nutrients. It sells its products through a network of independent distributors primarily under various brand names. The company was incorporated in 1950 and is headquartered in Mumbai, India.

General Outlook

When we look at how much money they make before expenses, they keep 0.631% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.249%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.226%. This tells us they're good at keeping money after all costs.

Return on Investments

Pfizer Limited's utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.155%.

Stock Prices

Pfizer Limited's stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $4477, while its low point bottomed out at $4236.65. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Pfizer Limited's stock market.

Profitability Ratios

PFIZER.BO profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 30.05% underscores its earnings before tax deductions. The effective tax rate stands at 24.71%, revealing its tax efficiency. The net income per EBT, 75.29%, and the EBT per EBIT, 120.65%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of 24.91%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin30.05%
Effective Tax Rate24.71%
Net Income per EBT75.29%
EBT per EBIT120.65%
EBIT per Revenue24.91%

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 109.76, and free cash flow per share, 109.76, depict cash generation on a per-share basis. The cash per share value, 413.61, showcases liquidity position. Lastly, the operating cash flow sales ratio, 0.23, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share109.76
Free Cash Flow per Share109.76
Cash per Share413.61
Operating Cash Flow Sales Ratio0.23
Free Cash Flow to Operating Cash Flow Ratio1.00
Dividend Payout Ratio0.02

Debt and Leverage Ratios

An interest coverage of 50.30 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Interest Coverage50.30

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 530.00, provides a glimpse into top-line earnings distributed across each share. Net income per share, 136.38, reflects the portion of profit attributed to each share. The book value per share, 701.04, represents the net asset value distributed per share, while the tangible book value per share, 576.08, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share530.00
Net Income Per Share136.38
Book Value Per Share701.04
Tangible Book Value Per Share576.08
Shareholders Equity Per Share701.04
Interest Debt Per Share32.32
Capex Per Share-14.20

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, -7.13%, indicates top-line expansion, while the gross profit growth, -6.73%, reveals profitability trends. EBIT growth, -2.24%, and operating income growth, -2.24%, offer insights into operational profitability progression. The net income growth, 1.86%, showcases bottom-line expansion, and the EPS growth, 1.86%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth-7.13%
Gross Profit Growth-6.73%
EBIT Growth-2.24%
Operating Income Growth-2.24%
Net Income Growth1.86%
EPS Growth1.86%
EPS Diluted Growth1.86%
Dividends per Share Growth86.06%
Operating Cash Flow Growth-46.68%
Free Cash Flow Growth-55.40%
10-Year Revenue Growth per Share66.84%
5-Year Revenue Growth per Share23.18%
3-Year Revenue Growth per Share12.70%
10-Year Operating CF Growth per Share1548.93%
5-Year Operating CF Growth per Share7.20%
3-Year Operating CF Growth per Share10.06%
10-Year Net Income Growth per Share-19.12%
5-Year Net Income Growth per Share73.28%
3-Year Net Income Growth per Share22.55%
10-Year Shareholders Equity Growth per Share23.46%
5-Year Shareholders Equity Growth per Share19.53%
3-Year Shareholders Equity Growth per Share-5.54%
10-Year Dividend per Share Growth per Share838.29%
5-Year Dividend per Share Growth per Share224.01%
3-Year Dividend per Share Growth per Share188.75%
Receivables Growth-20.10%
Inventory Growth-6.95%
Asset Growth2.57%
Book Value per Share Growth11.97%
Debt Growth-19.47%
SGA Expenses Growth17.67%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 159,453,413,570.8, captures the company's total value, considering both debt and equity. Income quality, 0.43, assesses the reliability of reported earnings. The ratio of intangibles to total assets, 14.29%, indicates the value of non-physical assets, and capex to operating cash flow, -18.27%, measures reinvestment capability.

cards.indicatorcards.value
Enterprise Value159,453,413,570.8
Income Quality0.43
Sales General and Administrative to Revenue0.11
Intangibles to Total Assets14.29%
Capex to Operating Cash Flow-18.27%
Capex to Revenue-2.68%
Capex to Depreciation-61.59%
Stock-Based Compensation to Revenue0.52%
Graham Number1466.68
Return on Tangible Assets18.20%
Graham Net Net315.18
Working Capital18,677,400,000
Tangible Asset Value26,355,800,000
Net Current Asset Value17,316,600,000
Average Receivables2,162,250,000
Average Payables2,405,000,000
Average Inventory4,333,000,000
Days Sales Outstanding29
Days Payables Outstanding91
Days of Inventory On Hand175
ROIC16.40%
ROE0.19%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 6.01, and the price to book ratio, 6.01, reflect the market's valuation relative to the company's book value. The price to sales ratio, 8.86, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, 39.17, and price to operating cash flows, 39.17, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio6.01
Price to Book Ratio6.01
Price to Sales Ratio8.86
Price Cash Flow Ratio39.17
Price Earnings to Growth Ratio21.06
Enterprise Value Multiple23.25
Price Fair Value6.01
Price to Operating Cash Flow Ratio39.17
Price to Free Cash Flows Ratio39.17
Price to Tangible Book Ratio4.94
Enterprise Value to Sales6.58
Enterprise Value Over EBITDA17.52
EV to Operating Cash Flow44.83
Earnings Yield3.94%
Free Cash Flow Yield1.83%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Pfizer Limited (PFIZER.BO) on the BSE in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is 39.166 in 2024.

What is the ticker symbol of Pfizer Limited stock?

The ticker symbol of Pfizer Limited stock is PFIZER.BO.

What is company IPO date?

IPO date of Pfizer Limited is 2000-01-17.

What is company current share price?

Current share price is 4108.650 INR.

What is stock market cap today?

The market cap of stock today is 187961419082.000.

What is PEG ratio in 2024?

The current 21.060 is 21.060 in 2024.

What is the number of employees in 2024?

In 2024 the company has 1702.